Common Contracts
5 similar Stock Purchase Agreement contracts by Crinetics Pharmaceuticals, Inc., Erasca, Inc., Gossamer Bio, Inc., others
ERASCA, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 28th, 2024 • Erasca, Inc. • Pharmaceutical preparations • New York
THIS STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of March 27, 2024 (the “Effective Date”), by and between ERASCA, INC., a Delaware corporation (the “Company”), and each of the purchasers whose names are set forth on Schedule A hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
ORIC PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • January 22nd, 2024 • Oric Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Stock Purchase Agreement (the “Agreement”) is made as of January 20, 2024 (the “Effective Date”), by and among ORIC Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
GOSSAMER BIO, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 13th, 2022 • Gossamer Bio, Inc. • Pharmaceutical preparations • New York
This Stock Purchase Agreement (the “Agreement”) is made as of July 12, 2022 (the “Effective Date”), by and among Gossamer Bio, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
CRINETICS PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 29th, 2021 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Stock Purchase Agreement (the “Agreement”) is made as of July 28, 2021 (the “Effective Date”), by and among Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
KRYSTAL BIOTECH, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 17th, 2018 • Krystal Biotech, Inc. • Biological products, (no disgnostic substances) • New York
This Stock Purchase Agreement (the “Agreement”) is made as of August 16, 2018 (the “Effective Date”), by and among Krystal Biotech, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
